|
AKBA Akebia Therapeutics Inc 1517022 |
| Balance Sheet |
|
Current Assets
|
$243,481,000.00 |
|
Assets
|
$362,520,000.00 |
|
Current Liabilities
|
$173,884,000.00 |
|
Liabilities
|
$335,145,000.00 |
|
Equity
|
$27,375,000.00 |
|
Shares Out
|
267898415.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,207,000.00 |
|
Investing Cash Flow
|
$-62,000.00 |
| Market Analysis |
Market Cap
|
$361,662,860.25 |
|
Price
|
$1.32 |
|
BVPS
|
0.10 |
|
PB
|
13.50 |
|
EPS
|
-0.03 |
|
PS
|
1.55 |
|
FCF
|
$-21,269,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.05 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.03 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
0.00 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
0.00 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKBA documents filed with the SEC.
AKBA Filings
Clear
